rs199759192
Variant names:
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_ModerateBP6_Moderate
The NM_020806.5(GPHN):c.144-10C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000118 in 1,496,866 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.000073 ( 0 hom., cov: 31)
Exomes 𝑓: 0.00012 ( 0 hom. )
Consequence
GPHN
NM_020806.5 intron
NM_020806.5 intron
Scores
2
Splicing: ADA: 0.0006119
2
Clinical Significance
Conservation
PhyloP100: 2.30
Genes affected
GPHN (HGNC:15465): (gephyrin) This gene encodes a neuronal assembly protein that anchors inhibitory neurotransmitter receptors to the postsynaptic cytoskeleton via high affinity binding to a receptor subunit domain and tubulin dimers. In nonneuronal tissues, the encoded protein is also required for molybdenum cofactor biosynthesis. Mutations in this gene may be associated with the neurological condition hyperplexia and also lead to molybdenum cofactor deficiency. Numerous alternatively spliced transcript variants encoding different isoforms have been described; however, the full-length nature of all transcript variants is not currently known. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_benign. The variant received -4 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.29).
BP6
Variant 14-66776454-C-T is Benign according to our data. Variant chr14-66776454-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 534552.Status of the report is criteria_provided_single_submitter, 1 stars.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000734 AC: 11AN: 149858Hom.: 0 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
11
AN:
149858
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0000557 AC: 14AN: 251160 AF XY: 0.0000663 show subpopulations
GnomAD2 exomes
AF:
AC:
14
AN:
251160
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000122 AC: 165AN: 1347008Hom.: 0 Cov.: 23 AF XY: 0.000120 AC XY: 81AN XY: 677210 show subpopulations
GnomAD4 exome
AF:
AC:
165
AN:
1347008
Hom.:
Cov.:
23
AF XY:
AC XY:
81
AN XY:
677210
Gnomad4 AFR exome
AF:
AC:
1
AN:
31202
Gnomad4 AMR exome
AF:
AC:
0
AN:
44558
Gnomad4 ASJ exome
AF:
AC:
0
AN:
25376
Gnomad4 EAS exome
AF:
AC:
0
AN:
39054
Gnomad4 SAS exome
AF:
AC:
0
AN:
83828
Gnomad4 FIN exome
AF:
AC:
0
AN:
53354
Gnomad4 NFE exome
AF:
AC:
158
AN:
1007676
Gnomad4 Remaining exome
AF:
AC:
5
AN:
56388
Heterozygous variant carriers
0
6
12
19
25
31
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0000734 AC: 11AN: 149858Hom.: 0 Cov.: 31 AF XY: 0.0000960 AC XY: 7AN XY: 72888 show subpopulations
GnomAD4 genome
AF:
AC:
11
AN:
149858
Hom.:
Cov.:
31
AF XY:
AC XY:
7
AN XY:
72888
Gnomad4 AFR
AF:
AC:
0.000024639
AN:
0.000024639
Gnomad4 AMR
AF:
AC:
0.0000671592
AN:
0.0000671592
Gnomad4 ASJ
AF:
AC:
0
AN:
0
Gnomad4 EAS
AF:
AC:
0
AN:
0
Gnomad4 SAS
AF:
AC:
0
AN:
0
Gnomad4 FIN
AF:
AC:
0
AN:
0
Gnomad4 NFE
AF:
AC:
0.000133065
AN:
0.000133065
Gnomad4 OTH
AF:
AC:
0
AN:
0
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Sulfite oxidase deficiency due to molybdenum cofactor deficiency type C Benign:1
Jan 05, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
Mutation Taster
=100/0
polymorphism
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
dbscSNV1_RF
Benign
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at